Published in J Clin Invest on July 01, 1983
Increased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjögren's syndrome. Matrix Biol (2007) 0.97
Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjögren's syndrome-like exocrinopathy. Exp Eye Res (2009) 0.89
Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome. Ann Rheum Dis (1992) 0.83
Expression of rheumatoid factor associated cross-reactive idiotopes by glandular B cells in Sjögren's syndrome. Clin Exp Immunol (1991) 0.81
A role for self-recognizing T cells in the regulation of antibody-forming and cell-mediated cytotoxic responses in the mouse. Immunology (1985) 0.75
Massive cutaneous follicular lymphoid hyperplasia in a patient with the Sjögren syndrome: 7-year follow-up and immunohistochemical study. Rheumatol Int (2006) 0.75
A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol (1981) 8.17
SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES. Medicine (Baltimore) (1965) 7.46
Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med (1981) 6.82
Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. Proc Natl Acad Sci U S A (1982) 5.85
Further characterization of the human inducer T cell subset defined by monoclonal antibody. J Immunol (1979) 5.63
Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci U S A (1981) 4.34
THE DEVELOPMENT OF MALIGNANT LYMPHOMA IN THE COURSE OF SJOEGREN'S SYNDROME. Am J Med (1964) 4.07
The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol (1974) 3.82
Antigen-induced selective recruitment of circulating lymphocytes. Cell Immunol (1971) 3.35
Extrasalivary lymphoid abnormalities in Sjögren's syndrome (reticulum cell sarcoma, "pseudolymphoma," macroglobulinemia). Am J Med (1967) 2.92
Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+. Proc Natl Acad Sci U S A (1982) 2.51
Abnormal migration of T lymphocyte clones. J Immunol (1982) 2.30
Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies. J Immunol (1983) 2.09
Sjogren's syndrome. I. Sicca components. Q J Med (1973) 2.08
Strategies for generating monoclonal antibodies defining human t-lymphocyte differentiation antigens. Transplant Proc (1980) 1.97
The monoclonality of human B-cell lymphomas. J Exp Med (1977) 1.97
Genetic differences between primary and secondary sicca syndrome. N Engl J Med (1979) 1.93
Biochemical studies of the human thymocyte cell-surface antigens T6, T9 and T10. Cell (1981) 1.92
Surface markers of cloned human T cells with various cytolytic activities. J Exp Med (1981) 1.87
T and B lymphocytes in peripheral blood and tissue lesions in Sjögren's syndrome. J Clin Invest (1974) 1.63
Use of monoclonal antibodies to analyze peripheral blood and salivary gland lymphocyte subsets in Sjögren's syndrome. Arthritis Rheum (1982) 1.58
Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med (1978) 1.54
Immunoglobulin synthesis by salivary gland lymphoid cells in Sjögren's syndrome. J Clin Invest (1970) 1.44
Autoantibodies and the spectrum of Sjögren's syndrome. Ann Intern Med (1979) 1.44
T gamma cells express T lymphocyte-associated antigens. J Immunol (1981) 1.17
NIH conference. A multidisciplinary approach to non-hodgkin's lymphomas. Ann Intern Med (1981) 1.04
Comparison in T- and B-cell markers in patients with Sjögren's syndrome and systemic lupus erythematosus. Clin Immunol Immunopathol (1982) 1.01
From benign polyclonal to malignant monoclonal lymphoproliferation in a patient with primary Sjögren's syndrome. Arthritis Rheum (1981) 1.00
Immunologically diagnosed malignancy in Sjögren's pseudolymphoma. Am J Med (1978) 0.97
Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides. J Clin Invest (1981) 0.96
Antibody-dependent cellular cytotoxicity and natural-killer-like activity are mediated by subsets of activated T cells. Clin Immunol Immunopathol (1981) 0.96
T lymphocyte-mediated cytotoxicity against autologous EBV-genome-bearing B cells. J Immunol (1981) 0.93
Chromosome 14 translocations in non-Burkitt lymphomas. Int J Cancer (1978) 0.89
Immunoblastic sarcoma with features of Sjögren's syndrome and systemic lupus erythematosus in a patient with immunoblastic lymphadenopathy. Arthritis Rheum (1979) 0.88
Specific marker chromosome 14 in malignant lymphomas. Nature (1976) 0.85
Letter: Sjögren's syndrome with light chain myeloma. West J Med (1975) 0.84
Structural characterization of the human T cell surface antigen (p67) isolated from normal and neoplastic lymphocytes. J Immunol (1982) 0.83
Abnormal immunoregulation in patients with non-Hodgkin's malignant lymphomas. I. Increased helper function of peripheral blood T lymphocytes. Clin Immunol Immunopathol (1982) 0.79
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis (2002) 20.48
A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med (1999) 11.62
Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest (1999) 7.69
Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum (1986) 6.11
Genetic analysis of simian virus 40. I. Description of microtitration and replica-plating techniques for virus. Virology (1970) 5.10
Genetic analysis of simian virus 40. 3. Characterization of a temperature-sensitive mutant blocked at an early stage of productive infection in monkey cells. J Virol (1972) 4.76
Maintenance of imaginal discs of Drosophila melanogaster in chemically defined media. J Cell Biol (1969) 3.76
Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. Proc Natl Acad Sci U S A (1981) 3.63
Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med (1999) 3.38
Effect of cell chromosome number on simian virus 40 replication. Exp Cell Res (1973) 3.20
A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science (1986) 2.91
The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea (1998) 2.86
Necrotizing sialometaplasia. A disease simulating malignancy. Cancer (1973) 2.79
Essential tremor is not dependent upon cerebellar Purkinje cell loss. Parkinsonism Relat Disord (2012) 2.76
Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun (2005) 2.69
Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood (1997) 2.55
Proposal for a uniform nomenclature for simian virus 40 mutants. J Virol (1972) 2.55
Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients. Chest (1998) 2.53
Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis. J Immunol (1982) 2.22
Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors. J Immunol (1984) 2.18
cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc Natl Acad Sci U S A (1991) 2.16
Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J Exp Med (1989) 2.15
The replication of murine coronaviruses in enucleated cells. Virology (1981) 2.14
IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol (1992) 2.09
Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies. J Immunol (1983) 2.09
Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. J Clin Invest (1999) 2.03
Pathogenic murine coronaviruses. II. Characterization of virus-specific proteins of murine coronaviruses JHMV and A59V. Virology (1979) 2.02
A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc Natl Acad Sci U S A (1979) 1.94
Altered protein metabolism in infection by the late tsB11 mutant of simian virus 40. J Virol (1974) 1.94
The inhibition of phagocytosis and facilitation of exocytosis in rabbit polymorphonuclear leukocytes by cytochalasin B. Lab Invest (1973) 1.89
Increased frequency of rheumatoid factor precursor B lymphocytes after immunization of normal adults with tetanus toxoid. Clin Exp Immunol (1983) 1.88
Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology (2006) 1.81
Primary Sjogren syndrome: clinical and immunopathologic features. Semin Arthritis Rheum (1984) 1.75
Crystal structure of a calcium-phospholipid binding domain from cytosolic phospholipase A2. J Biol Chem (1998) 1.75
Cerebellar Purkinje cell loss is not pathognomonic of essential tremor. Parkinsonism Relat Disord (2011) 1.73
Pathogenic murine coronaviruses. I. Characterization of biological behavior in vitro and virus-specific intracellular RNA of strongly neurotropic JHMV and weakly neurotropic A59V viruses. Virology (1979) 1.71
Rheumatoid factor and immune networks. Annu Rev Immunol (1987) 1.70
Validation of conditions for efficient detection of HPRT and APRT mutations in suspension-cultured Chinese hamster ovary cells. Mutat Res (1980) 1.67
A common idiotope on human rheumatoid factors identified by a hybridoma antibody. Mol Immunol (1983) 1.65
Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis. Arthritis Rheum (1984) 1.65
Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. J Biol Chem (1988) 1.63
Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome. J Immunol (1986) 1.62
Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice. J Exp Med (1990) 1.61
Association of diffuse idiopathic skeletal hyperostosis (DISH) and calcification and ossification of the posterior longitudinal ligament. AJR Am J Roentgenol (1978) 1.60
Course in Parkinson disease subtypes: A 39-year clinicopathologic study. Neurology (2009) 1.59
Use of monoclonal antibodies to analyze peripheral blood and salivary gland lymphocyte subsets in Sjögren's syndrome. Arthritis Rheum (1982) 1.58
T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides. Arthritis Rheum (1998) 1.55
Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma. Eur J Immunol (1985) 1.55
Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum (1984) 1.53
Anti-hypervariable region antibody induced by a defined peptide: an approach for studying the structural correlates of idiotypes. Proc Natl Acad Sci U S A (1984) 1.50
Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. J Clin Invest (1990) 1.49
Central venous catheters revisited--infection rates and an assessment of the new Fibrin Analysing System brush. Anaesth Intensive Care (1996) 1.49
Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br J Cancer (1990) 1.48
Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies. J Clin Invest (1986) 1.46
Is there justification for using indomethacin in preterm labor? An analysis of neonatal risks and benefits. Am J Obstet Gynecol (1997) 1.45
Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis. Exp Cell Res (1996) 1.45
Inheritance of immunoglobulin M rheumatoid-factor idiotypes. J Clin Invest (1980) 1.41
Regulation of immune response by components of the complement cascade and their activated fragments. Springer Semin Immunopathol (1983) 1.41
Delineation of a cross-reactive idiotype on human autoantibodies with antibody against a synthetic peptide. J Exp Med (1984) 1.40
The majority of human monoclonal IgM rheumatoid factors express a "primary structure-dependent" cross-reactive idiotype. J Immunol (1985) 1.40
Incidence of three cross-reactive idiotypes on human rheumatoid factor paraproteins. J Immunol (1988) 1.39
Idiotypic and subgroup analysis of human monoclonal rheumatoid factors. Implications for structural and genetic basis of autoantibodies in humans. J Clin Invest (1988) 1.38
Expression of three cross-reactive idiotypes on rheumatoid factor autoantibodies from patients with autoimmune diseases and seropositive adults. J Immunol (1986) 1.37
Activation of the classical pathway of complement by rheumatoid factors. Assessment by radioimmunoassay for C4. Arthritis Rheum (1982) 1.37
Child dental health survey. Br Dent J (1995) 1.37
Partitioning of HIV-1 Gag and Gag-related proteins to membranes. Biochemistry (1996) 1.36
High-frequency expression of a conserved kappa light-chain variable-region gene in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (1987) 1.35
Characterization of an epibody. An antiidiotype that reacts with both the idiotype of rheumatoid factors (RF) and the antigen recognized by RF. J Exp Med (1985) 1.32
Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome. Arthritis Rheum (1990) 1.28
Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am J Pathol (1994) 1.28
Identification of an N-cadherin motif that can interact with the fibroblast growth factor receptor and is required for axonal growth. J Biol Chem (2001) 1.24
Antigenic phenotypes and complementation groups of temperature-sensitive mutants of simian virus 40. J Virol (1974) 1.24
Propranolol and the treatment of rheumatoid arthritis. Arthritis Rheum (1980) 1.23
Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjögren's syndrome. Arthritis Rheum (1986) 1.22
Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans. J Immunol (1986) 1.22
Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b. J Immunol (1983) 1.22
Verruciform xanthoma. A clinicopathologic review and report of fifty-four cases. Oral Surg Oral Med Oral Pathol (1981) 1.22
Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulation. Am J Physiol Cell Physiol (2000) 1.21
Synthesis of viral ribonucleic acid during restricted adenovirus infection. J Virol (1972) 1.19
Trabecular bone mineral density in idiopathic scoliosis. J Pediatr Orthop (1987) 1.19
Soluble N-cadherin stimulates fibroblast growth factor receptor dependent neurite outgrowth and N-cadherin and the fibroblast growth factor receptor co-cluster in cells. J Neurochem (2001) 1.19
A unified theory of the role of the ocular surface in dry eye. Adv Exp Med Biol (1998) 1.19
Identification of simian virus 40 tumor and U antigens. Proc Natl Acad Sci U S A (1977) 1.17
T gamma cells express T lymphocyte-associated antigens. J Immunol (1981) 1.17
C5a-mediated release of interleukin 6 by human monocytes. Clin Immunol Immunopathol (1990) 1.16
Reciprocal trust in health care relationships. J Adv Nurs (1988) 1.16
Elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis. Arthritis Rheum (1984) 1.16
Guarded alliance: health care relationships in chronic illness. Image J Nurs Sch (1989) 1.16